We demonstrated that PKM2 activation alleviated the aberrant glycolytic flux, decreased PGC-1α expression, and impaired FAO and mitochondrial metabolism and function in HG-treated RTECs and mice with diabetes. The gene discussed is PKM; the disease is diabetes mellitus.